Hospital
Central Valley Medical Center
Central Valley Medical Center was paid $2.28M by Medicaid between Jan 2018 and Oct 2024, across 62 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 30% of everything it billed.
33Billing provider infoCENTRAL VALLEY MEDICAL CENTER
NEPHI, UT 84648
NEPHI, UT 84648
33aNPI1881658110assigned 04/13/2006
33bProvider typeCritical Access Hospital
28Total paid$2.28M
24GClaims49,647
24DCodes billed62
24AFirst – last monthJan 2018 – Oct 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,825 | $213K | |
| 2019 | 7,137 | $259K | |
| 2020 | 8,637 | $492K | |
| 2021 | 12,573 | $593K | |
| 2022 | 11,999 | $649K | |
| 2023 | 1,683 | $43K | |
| 2024incomplete | 793 | $29K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 30% | 2,814 | 823 | $680K |
| 36415 | Collection of venous blood by venipuncture | 12% | 8,277 | 6,657 | $271K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8.9% | 1,077 | 937 | $203K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.7% | 4,689 | 3,969 | $153K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 936 | 830 | $130K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.7% | 2,106 | 1,863 | $107K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.7% | 1,839 | 1,676 | $107K |
| 86140 | 4.2% | 2,578 | 2,216 | $97K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.5% | 1,769 | 1,630 | $80K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.5% | 567 | 546 | $57K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2.0% | 238 | 218 | $46K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 1,105 | 937 | $38K |
50 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 1,767 | $33K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1.3% | 864 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 1,441 | $28K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.0% | 567 | $23K |
| 87088 | <1% | 783 | $23K | |
| 81000 | <1% | 1,095 | $20K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 258 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,411 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 484 | $18K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 451 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 395 | $9K |
| 85379 | <1% | 306 | $8K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,157 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 87 | $7K |
| 87186 | <1% | 59 | $6K | |
| 84703 | <1% | 541 | $6K | |
| 80050 | General health panel | <1% | 289 | $5K |
| 81015 | <1% | 1,056 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 84 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 80 | $4K |
| 81002 | <1% | 1,467 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 96 | $3K |
| 73630 | <1% | 33 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 225 | $2K |
| 97161 | <1% | 26 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 743 | $2K |
| 80061 | Lipid panel | <1% | 278 | $2K |
| 86756 | <1% | 16 | $1K | |
| 83605 | <1% | 256 | $895.25 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 48 | $719.45 |
| 83690 | <1% | 155 | $610.30 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 630 | $590.07 |
| 82728 | <1% | 12 | $336.64 | |
| 84484 | <1% | 339 | $294.89 | |
| 83880 | <1% | 40 | $206.87 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 176 | $108.96 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 24 | $88.66 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 61 | $0.00 |
| 94760 | 0% | 19 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 32 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 483 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 57 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 66 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 25 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 90 | $0.00 |
| 94664 | 0% | 28 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 13 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 13 | $0.00 |
| 85007 | 0% | 14 | $0.00 | |
| 86900 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTODDARD, MARK (ADMINISTRATOR)